BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37476952)

  • 1. Investigating the potential link between lunar cycle and multiple sclerosis relapses: a call for further studies.
    Yousfi N; Mrabet S; Ben Saad H; Chamari K
    Libyan J Med; 2023 Dec; 18(1):2238354. PubMed ID: 37476952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus, latitude and multiple sclerosis.
    Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
    Wingerchuk DM
    Mt Sinai J Med; 2011; 78(2):221-30. PubMed ID: 21425266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 5. MULTIPLE SCLEROSIS - RISK FACTORS.
    Adamczyk-Sowa M; Gębka-Kępińska B; Kępiński M
    Wiad Lek; 2020; 73(12 cz 1):2677-2682. PubMed ID: 33577489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental factors in multiple sclerosis.
    Pantazou V; Schluep M; Du Pasquier R
    Presse Med; 2015 Apr; 44(4 Pt 2):e113-20. PubMed ID: 25744944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
    Bjornevik K; Cortese M; Healy BC; Kuhle J; Mina MJ; Leng Y; Elledge SJ; Niebuhr DW; Scher AI; Munger KL; Ascherio A
    Science; 2022 Jan; 375(6578):296-301. PubMed ID: 35025605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
    McKay KA; Jahanfar S; Duggan T; Tkachuk S; Tremlett H
    Neurotoxicology; 2017 Jul; 61():189-212. PubMed ID: 27045883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
    O'Gorman C; Lucas R; Taylor B
    Int J Mol Sci; 2012; 13(9):11718-11752. PubMed ID: 23109880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D.
    Latifi T; Zebardast A; Marashi SM
    Mult Scler Relat Disord; 2022 Jan; 57():103318. PubMed ID: 35158423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milk and multiple sclerosis: A possible link?
    Morin CR; Baeva ME; Hollenberg MD; Brain MC
    Mult Scler Relat Disord; 2024 Mar; 83():105477. PubMed ID: 38308914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection by Epstein-Barr virus and multiple sclerosis].
    Alonso A; Egüés Olazábal N; Ayo Martín O
    Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and multiple sclerosis: association or causation?
    Pakpoor J; Giovannoni G; Ramagopalan SV
    Expert Rev Neurother; 2013 Mar; 13(3):287-97. PubMed ID: 23448218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low sun exposure acts synergistically with high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels in multiple sclerosis etiology.
    Hedström AK; Huang J; Brenner N; Butt J; Kockum I; Waterboer T; Olsson T; Alfredsson L
    Eur J Neurol; 2021 Dec; 28(12):4146-4152. PubMed ID: 34435414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: risk factors and their interactions.
    Disanto G; Morahan JM; Ramagopalan SV
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):545-55. PubMed ID: 22583442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
    Pakpoor J; Disanto G; Gerber JE; Dobson R; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Feb; 19(2):162-6. PubMed ID: 22740437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental factors in multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):3-9. PubMed ID: 24289836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients.
    Pérez-Pérez S; Cuello JP; Martínez-Ginés M; Pardo-Rodríguez B; García-Domínguez JM; Domínguez-Mozo MI; Lozano-Ros A; García-Martínez MÁ; Higueras Y; Meldaña-Rivera A; Goicochea-Briceño H; Tejeda-Velarde A; Fernández-Velasco JI; Medina S; Arroyo R; Villar LM; Álvarez-Lafuente R
    Sci Rep; 2021 Apr; 11(1):8441. PubMed ID: 33875702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.